PPBP | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CEACAM6 | Carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FUT4 | Fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific) | Predicted membrane proteins
| | | | | Tissue enriched |
HYAL3 | Hyaluronoglucosaminidase 3 | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ITGAM | Integrin, alpha M (complement component 3 receptor 3 subunit) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins
| | | | | Group enriched |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
TREM1 | Triggering receptor expressed on myeloid cells 1 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
ADAM8 | ADAM metallopeptidase domain 8 | CD markers Enzymes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALOX5 | Arachidonate 5-lipoxygenase | Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
APOBEC3A | Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A | | | | | | Tissue enhanced |
ARG1 | Arginase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
C17orf53 | Chromosome 17 open reading frame 53 | | | | | | Tissue enhanced |
CCNE1 | Cyclin E1 | Cancer-related genes
| | | | | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CD83 | CD83 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
CDA | Cytidine deaminase | Enzymes Plasma proteins
| | | | | Tissue enhanced |
CDCA4 | Cell division cycle associated 4 | | | | | | Tissue enhanced |
CDCA5 | Cell division cycle associated 5 | | | | | | Tissue enhanced |
CENPF | Centromere protein F, 350/400kDa | Cancer-related genes Plasma proteins
| | | | | Tissue enhanced |
CENPU | Centromere protein U | | | | | | Tissue enhanced |
CKAP2L | Cytoskeleton associated protein 2-like | | | | | | Tissue enhanced |
CLC | Charcot-Leyden crystal galectin | | | | | | Tissue enhanced |
CLEC12A | C-type lectin domain family 12, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CTSW | Cathepsin W | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP4F3 | Cytochrome P450, family 4, subfamily F, polypeptide 3 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
DPPA4 | Developmental pluripotency associated 4 | | | | | | Tissue enhanced |
DTL | Denticleless E3 ubiquitin protein ligase homolog (Drosophila) | | | | | | Tissue enhanced |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
EXO1 | Exonuclease 1 | | | | | | Tissue enhanced |
FBXO5 | F-box protein 5 | | | | | | Tissue enhanced |
GFI1 | Growth factor independent 1 transcription repressor | Disease related genes Transcription factors
| | | | | Tissue enhanced |
GLT1D1 | Glycosyltransferase 1 domain containing 1 | | | | | | Tissue enhanced |
GNLY | Granulysin | Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
GP9 | Glycoprotein IX (platelet) | CD markers Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GZMB | Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HIST1H2AB | Histone cluster 1, H2ab | | | | | | Tissue enhanced |
HIST1H2BI | Histone cluster 1, H2bi | Plasma proteins
| | | | | Tissue enhanced |
HIST1H2BM | Histone cluster 1, H2bm | | | | | | Tissue enhanced |
HIST1H2BO | Histone cluster 1, H2bo | | | | | | Tissue enhanced |
HIST1H3A | Histone cluster 1, H3a | | | | | | Tissue enhanced |
HIST1H3F | Histone cluster 1, H3f | | | | | | Tissue enhanced |
HIST1H3H | Histone cluster 1, H3h | | | | | | Tissue enhanced |
HJURP | Holliday junction recognition protein | | | | | | Tissue enhanced |
HK3 | Hexokinase 3 (white cell) | Enzymes Plasma proteins
| | | | | Tissue enhanced |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
IL18RAP | Interleukin 18 receptor accessory protein | CD markers Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ITGA2B | Integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41) | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
KIAA0101 | KIAA0101 | Mitochondrial proteins
| | | | | Tissue enhanced |
KIF21B | Kinesin family member 21B | Plasma proteins
| | | | | Tissue enhanced |